Coris BioConcept is a leading expert in the field of immunochromatographic (IC) and oligochromatographic (OC) technologies. Based in Belgium and established in 1996 by Thierry Leclipteux (CEO), the company develops, produces and markets diagnostic kits, mainly for the detection of human respiratory and gastro-enteric infectious pathogens (bacteria, virus and parasites), and for the detection of antibiotic resistance markers (RESIST products). These rapid tests are extensively used in microbiology laboratories worldwide. To complement this extensive range of fast and accurate lateral flow tests, the company has developed an innovative fully automated platform that performs multiplex PCR amplification and detection, on a microfluidic cartridge (TRAPIST products). This molecular multiplex plateform allows syndromic diagnostic approach for the clinical management of main human infections like in sepsis, meningitidis, respiratory and enteric diseases. Coris BioConcept is currently involved in multiple collaborative international projects (under Belgian and/or European grants) for the development of class-B metallo-betalactamase rapid IC tests, fast and unique nucleic acid extraction system from blood cultures, nanotechnology solution to fight against multi-drug resistant bacteria, and much more projects. This R&D expertise is ideally suited for the “on-demand” production of innovative solutions in a rapidly changing world that calls for cutting edge biotechnology to take us forward into a healthy future. All Coris BioConcept’s products fulfill the CE marking requirements and the company is also certified ISO 1 3485.